C Franken

780 total citations
19 papers, 664 citations indexed

About

C Franken is a scholar working on Pulmonary and Respiratory Medicine, Nutrition and Dietetics and Molecular Biology. According to data from OpenAlex, C Franken has authored 19 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Nutrition and Dietetics and 4 papers in Molecular Biology. Recurrent topics in C Franken's work include Infant Nutrition and Health (5 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Pulmonary Hypertension Research and Treatments (4 papers). C Franken is often cited by papers focused on Infant Nutrition and Health (5 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Pulmonary Hypertension Research and Treatments (4 papers). C Franken collaborates with scholars based in Netherlands, Germany and United States. C Franken's co-authors include Joop H. Dijkman, C J Meijer, J. A. Kramps, Jack Fransen, E.C. Klasen, W.S. Volkers, Johannes A. Kramps, Luigi F. Bernini, Ank A. W. Ten Have‐Opbroek and John J. Hermans and has published in prestigious journals such as CHEST Journal, Annals of the Rheumatic Diseases and European Respiratory Journal.

In The Last Decade

C Franken

19 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Franken Netherlands 12 274 190 129 119 91 19 664
J.M. Tournier France 16 238 0.9× 260 1.4× 165 1.3× 123 1.0× 39 0.4× 19 674
Steven E. Suter United States 19 573 2.1× 250 1.3× 92 0.7× 92 0.8× 177 1.9× 58 987
Kristen L. Veraldi United States 12 270 1.0× 289 1.5× 37 0.3× 68 0.6× 62 0.7× 20 725
Albert Taiching Liao Taiwan 17 272 1.0× 231 1.2× 54 0.4× 123 1.0× 108 1.2× 41 670
Mark KuKuruga United States 18 85 0.3× 215 1.1× 52 0.4× 189 1.6× 360 4.0× 40 921
B Dyer United States 5 72 0.3× 140 0.7× 30 0.2× 156 1.3× 337 3.7× 7 604
Mona P. Rosenberg United States 12 622 2.3× 148 0.8× 36 0.3× 162 1.4× 154 1.7× 16 854
Olivier Feugeas France 8 132 0.5× 389 2.0× 39 0.3× 113 0.9× 55 0.6× 17 718
Midori Mitui United States 18 132 0.5× 608 3.2× 288 2.2× 160 1.3× 35 0.4× 31 940
Ya‐Ping Ko Germany 12 62 0.2× 222 1.2× 77 0.6× 87 0.7× 55 0.6× 14 532

Countries citing papers authored by C Franken

Since Specialization
Citations

This map shows the geographic impact of C Franken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Franken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Franken more than expected).

Fields of papers citing papers by C Franken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Franken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Franken. The network helps show where C Franken may publish in the future.

Co-authorship network of co-authors of C Franken

This figure shows the co-authorship network connecting the top 25 collaborators of C Franken. A scholar is included among the top collaborators of C Franken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Franken. C Franken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kardos, Péter, et al.. (2020). Duplicate Prescriptions of Inhaled Medications for Obstructive Lung Diseases. Pneumologie. 74(3). 149–158. 2 indexed citations
2.
Franken, C, et al.. (1992). Protective effect of pulmonary surfactant on elastase-induced emphysema in mice. European Respiratory Journal. 5(10). 1223–1230. 25 indexed citations
3.
Franken, C, et al.. (1991). Lack of type II cells and emphysema in human lungs. European Respiratory Journal. 4(3). 316–323. 13 indexed citations
4.
Franken, C, C J Meijer, & Joop H. Dijkman. (1989). Tissue distribution of antileukoprotease and lysozyme in humans.. Journal of Histochemistry & Cytochemistry. 37(4). 493–498. 145 indexed citations
5.
Kramps, J. A., et al.. (1988). Antileukoprotease, its role in the human lung.. PubMed. 369 Suppl. 83–7. 9 indexed citations
6.
Kramps, Johannes A., C Franken, & Joop H. Dijkman. (1988). Quantity of anti-leucoprotease relative to α1-proteinase inhibitor in peripheral airspaces of the human lung. Clinical Science. 75(4). 351–353. 34 indexed citations
7.
Have‐Opbroek, Ank A. W. Ten, et al.. (1988). Detection of the type II cell or its precursor before week 20 of human gestation, using antibodies against surfactant-associated proteins. Anatomy and Embryology. 178(1). 29–39. 29 indexed citations
8.
Willems, Luc, J. A. Kramps, R. de Water, et al.. (1986). Evaluation of antileukoprotease in surgical lung specimens.. PubMed. 69(4). 242–7. 7 indexed citations
9.
Dijkman, Joop H., J. A. Kramps, & C Franken. (1986). Antileukoprotease in Sputum during Bronchial Infections. CHEST Journal. 89(5). 731–736. 13 indexed citations
10.
Franken, C, et al.. (1986). Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies.. PubMed. 133(5). 882–90. 96 indexed citations
11.
Macfarlane, J. D., et al.. (1984). Progressive cavitating pulmonary changes in rheumatoid arthritis: a case report.. Annals of the Rheumatic Diseases. 43(1). 98–101. 7 indexed citations
12.
Kramps, J. A., C Franken, & Joop H. Dijkman. (1984). ELISA for quantitative measurement of low-molecular-weight bronchial protease inhibitor in human sputum.. PubMed. 129(6). 959–63. 66 indexed citations
13.
Kramps, J. A., et al.. (1983). Localisation of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung.. Thorax. 38(3). 180–183. 57 indexed citations
14.
Franken, C, et al.. (1982). Enzymes and enzyme-inhibitors in the small airways.. PubMed. 121. 53–9. 5 indexed citations
15.
Kramps, Johannes A. & C Franken. (1982). Low-molecular-weight protease inhibitor of the respiratory tract. PubMed. 1(1). 30–36. 2 indexed citations
16.
Kramps, J. A., et al.. (1982). Ultrastructural localization of the low molecular weight protease inhibitor in human bronchial glands.. Journal of Histochemistry & Cytochemistry. 30(11). 1130–1134. 21 indexed citations
17.
Kramps, J. A., C Franken, C J Meijer, & Joop H. Dijkman. (1981). Localization of low molecular weight protease inhibitor in serous secretory cells of the respiratory tract.. Journal of Histochemistry & Cytochemistry. 29(6). 712–719. 78 indexed citations
18.
Franken, C, et al.. (1981). LOCALIZATION OF A LOW MOLECULAR WEIGHT PROTEASE INHIBITOR IN THE RESPIRATORY TRACT. Elsevier eBooks. 16 Suppl. 231–236. 8 indexed citations
19.
Klasen, E.C., C Franken, W.S. Volkers, & Luigi F. Bernini. (1977). Population genetics of ?1-Antitrypsin in the Netherlands. Human Genetics. 37(3). 303–313. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026